HSBC Holdings’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
CF
MBAM
HSBC Holdings's HCAT Position: Q3 2026 in Review
HSBC Holdings reduced its Health Catalyst (HCAT) stake by 79% in Q3 2026, selling an estimated $617K and leaving 85,310 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #2708.
HSBC Holdings first reported a position in HCAT in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.39M in Q3 2021. 107 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.
- HSBC Holdings held 85,310 shares of Health Catalyst worth $150K as of Q3 2026.
- HSBC Holdings sold 323,324 Health Catalyst shares in Q3 2026, an estimated $617K.
- Health Catalyst made up ﹤0.01% of HSBC Holdings's portfolio in Q3 2026, its #2708 holding.
- HSBC Holdings first reported a position in Health Catalyst in Q2 2021 and has held it in 18 quarters since.
- HSBC Holdings's Health Catalyst position peaked at $1.39M in Q3 2021.
- 107 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.
Based on HSBC Holdings's 13F filing for Q3 2026, filed 16 Nov 2026.